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POINT OF VIEW 
EDITORS' NOTE: As many readers have recognized, a "Point of View" section has 
been recently developed in the Journal. The Editors believe that the Point of View 
section provides a valuable service and a sounding board for new ideas and solu- 
tions to critical issues and problems that face the discipline of vascular surgery. The 
Editors wish to emphasize that such Points of View are personal opinions, observa- 
tions, and conclusions and do not necessarily reflect he opinions and policies of the 
Journal of Vascular Surgery or its two sponsoring organizations, The Society for 
Vascular Surgery and The North American Chapter of the International Society for 
Cardiovascular Surgery. 
Calvin B. Ernst, MD 
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for Vascular Surgery: A look at 
A famous Dane once remarked that predicting is diffficult-- 
particularly the future. It is a doubly daunting challenge to predict 
the future of an esteemed organization such as The Society for 
Vascular Surgery (SVS) at a time of great upheaval in medicine in 
general. Clearly this upheaval nd the rapid pace of technologic 
innovation will have a great impact on the future of the specialty of 
vascular surgery. The SVS must help vascular surgeons and their 
specialty adapt to this changing world in an optimal fashion that 
strengthens vascular surgery and increases its value in the care and 
well-being of vascular disease patients. 
FORCES IMPACTING VASCULAR SURGERY IN  
THE NEXT TWO TO 
THREE DECADES 
Techno log ic  and  scient i f ic  advances.  It is not possible to 
hold back progress. Moreover, the human mind's capacity for 
innovation has few limits. Vascular disease treatment is currently an 
area of great innovation. We are currently at the threshold of a new 
era in minimally invasive and noninvasive imaging of blood vessels 
and their lesions. These advances in maging will revolutionize what 
we do in the treatment of vascular disease. Magnetic resonance 
angiography, spiral computed tomographic s anning, color duplex 
ultrasonography, and intravascular ultrasonography will become 
better and better. Computer-enhanced displays, projections, and 
three-dimensional modeling based on the new data from these 
From the Division of Vascular Surgery and the Department of 
Surgery, Montefiore Medical Center-Albert Einstein College of 
Medicine, New York, N.Y. 
Reprint requests: Frank J. Veith, MD, Montefiore Medical Center, 
111 East 210th St., New York, NY 10467. 
J Vasc Surg 1996;24:144-7. 
Copyright © 1996 by The Society for Vascular Surgery and 
International Society for Cardiovascular Surgery, North Ameri- 
can Chapter. 
0741-5214/96/$5.00 + 0 24 /1 /73769 
144  
methods will more perfectly reflect in-vivo anatomy and disease. 
Diagnostic angiography as we presently know it will probably 
become obsolete and unnecessary. Intraoperatlve digital cinefluo- 
roscopy will become an essential adjunct for the performance of 
most standard vascular operations, as it already has for balloon 
catheter thromboembolectomy. 1 This will mean that vascular 
surgeons mustmaster catheter-guidewire skills so that they can use 
this improved imaging technique to perform standard operations 
adequately. 
Another technologic advance involves innovative new devices 
that will greatly expand the horizon of endovascular treatments of
vascular lesions. What currently can be accomplished with transhi- 
minally introduced balloons, stents, and stented grafts is only the 
beginning. It is highly probable that improvements in these devices 
and the methods for their use will allow more than 50% of vascular 
lesions that in the past could be treated only with open operation to 
be treated by a less-invasive transluminal or endovascular ap- 
proach. 2'3 This will apply to occlusive and traumatic lesions as well 
as aneurysms. Although the comparative safety, efficacy, and 
effectiveness of these new endovascular treatments for each type of 
lesion in each location wili have to be proven by scientifically valid 
comparative performance studies, 4 it is likely that many of them will 
prove to be safe and effective, at least in some circumstances. If that 
occurs, these techniques will surely replace older open operative 
methods of treatment. This replacement is assured because ffec- 
tive endovascular t eatment methods have intrinsic advantages 
both for patients and for physicians in terms of decreased morbidity 
rates, risk, requirement for hospitalization, and ultimately costs. Of 
course, these potential benefits must be proved, and such compara- 
tive performance studies will occupy vascular surgeons and others 
interested in vascular disease treatment for some time to come. 
A final technical or scientific advance that will influence 
vascular surgery is the introduction of better biochemical orgenetic 
methods to prevent or reverse atherosclerosis, intimal hyperplasia, 
and degenerative aneurysms. These new treatment methods will be 
administered in two forms; one will be systemic by oral orparenteral 
routes, the other will be local by an endovascular route. The 
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advantage of genetic therapy over other biochemical manipulations 
is the requirement for ouly a single treatment as opposed to the 
need for repetitive maintenance therapy. Although the concept of 
a pill or an injection to prevent or reverse atherosclerosis, intimal 
hyperplasia, oraneurysms seems far-fetched and futuristic, progress 
in both biochemical nd genetic treatments has already been made, 
and it is inevitable that further advances will be made. Although 
such treatments will probably not be effective in every patient or 
every circumstance, the likelihood is that new treatments will 
obviate the need for interventional or surgical treatment in some 
patients. Accordingly, they may influence future vascular worlcforce 
requirements and decrease the need for vascular surgeons. 
Inc reased  ag ing  popu la t ion .  In the next several decades, 
as the baby boomers reach their golden years and as longevity 
increases for the population in general, the proportion of elderly 
patients in the U.S. population will increase sharply. In 1992, 12.2% 
of the population was more than 65 years of age. In 2020, if the 
current rends continue," 16.5% of people in the United States will 
exceed 65 years of age, an increase of 35% in the elderly, s,6 Because 
elderly people make up the bulk of the patients who require vascular 
procedures, this increased proportion of elderly patients could 
increase the need for vascular surgeons, as Dr. Stanley and his 
Vascular Surgery Workforce Committee have predicted] Whether 
this increased need for vascular surgeons will be offset by other 
influences, such as scientific advances in the control of vascular 
disease, the entry of other specialists into the vascular disease field, 
or the changing financial support for medical care, remains to be 
determined. 
Chang ing  f inancia l  suppor t - -managed care. Rising 
health care costs are perceived by our government, by our major 
employers, and by the public at large as a major national problem 
that must be attacked and controlled. As a result, government 
funding for health care is decreasing, and so-called managed care 
systems are being promoted. These systems provide financial 
incentives to limit the use of expensive specialty care, such as that 
required by many vascular disease patients. One result of  these new 
financial pressures will be to reduce incentives to perform unnec- 
essary proccdurcs and to increase incentives to provide cost- 
effective care--which are both good effects. The same pressures 
may also prevent or delay some patients from recciving the care they 
need to preserve their life and well-being--a bad effect. Whether 
the good effects outweigh the bad effects or vice versa remains to 
be seen. It is clear, however, that these financial pressures will result 
in a decreased number of vascular surgical procedures 
and the need for fewer vascular surgeons. 
Chang ing  mot ives  and  background t ra in ing  fo r  
t reat ing  vascular  d isease pat ients .  The impact of all these 
fiscal considerations on future vascular surgery workforce require- 
ments will also be influenced by the efforts of other individuals or 
specialities to assume the care of vascular disease patients. This is an 
area that until now in the United States has largely been left to 
vascular surgeons because of its complexity, its demands for 
technical perfection when intervention is required, and the fact that 
most patients who are easy to treat are best treated in a noninter- 
ventional manner, whereas most patients who truly require invasive 
treatment are difficult o treat. 8However, because of changes in the 
financial support for medicine, shfinldng patient loads, and exces- 
sive numbers of new specialists, other physicians with less training 
and experience in all forms of vascular disease management will be 
motivated to increase their therapeutic horizons to include vascular 
disease patients. These other physicians include general surgeons, 
who have some basic skills to perform simple vascular operations. 
They also indude interventional radiologists and cardiologists, who 
may be moved by the same forces and, in addition, are increasingly 
being provided with new endovascular tools for treating vascular 
lesions. These specialty shifts are potentially dangerous because 
they may result in patients receiving care that is not in their best 
interests. The simple mastery of a technique or skill--be it surgical 
or interventional--for treating lesions should not alone qualify a 
physician to treat vascular disease patients. 
Mthough some interventional radiologists and a few interven- 
tional cardiologists and general surgeons, by virtue of adequate 
training, experience, and commitment, have a clear understanding 
of peripheral vascular disease natural history and which patients 
require treatment and which do not, many practitioners of these 
specialties do not possess this lmowledge, experience, or commit- 
ment. Their interests lie in treating lesions rather than patients, an 
approach that clearly may be harmful to patients' long-term best 
interests. The challenge for these individuals is to obtain this 
knowledge by appropriate raining th~,t exposes them to all forms of 
treatment, including conservative measures, or to collaborate with 
vascular surgeons or others who have this knowledge. The over- 
riding principle that should determine who cares for vascular 
patients hould be the mastery of the increasing body of  specialized 
knowledge and skills that allows vascular patients to be treated 
optimally--that is, most efficiently, most safely, and most cost- 
effectively. In general, the attainment of these sldlls requires a 
period of training in non-cardiac vascular disease management of 1 
to 2 years, or a comparable l vel of practice xperience. Another 
acceptable alternative isparticipation i a multidisciplinary group 
that provides this level of  experience and expertise. 
THE FUTURE ROLE OF  THE SVS 
Although some of the forces and realities already discussed may 
impact negatively on vascular surgery, the specialty should and will 
survive as an entity because it cncompasses a discrete body of 
knowledge and discrete skills, the mastery of which results in 
improved care for patients with non-cardiac vascular disease. 
Indeed, it is fulfillment of just this purpose that provides the basic 
justification for specialty board recognition. 9 
If  vascular surgery survives as a specialty, there will be a 
purpose and need for the SVS, and it too will survive. As the SVS has 
provided leadership for vascular surgery in the past, so too must it 
provide this leadership in the future. Indeed, the primary goal for 
the Society is to provide the leadership to help vascular surgery and 
the vascular disease patients for whom it cares to cope in an optimal 
fashion with the changes that are occurring in medicine and the 
forces and realities already outlined. 
Re la t ionsh ip  to  the  In ternat iona l  Soc iety  fo r  Car-  
d iovascu lar  Surgery,  Nor th  Amer ican  Chapter .  The SVS 
was founded in 1947. Its original bylaws stated that 
the objects of this Society shall be (1) to promote the study 
of and research in vascular diseases; (2) to define more clearly 
the role of surgery in these diseases; (3) to pool the 
experience and knowledge of the membership in order to 
standardize methods of studying and managing these 
diseases; (4) to standardize the nomenclature of these 
diseases; (5) to promote and encourage adequate t aching of 
these diseases to students, interns and residents; (6) to 
encourage hospitals to develop special training for young 
surgeons in this field; (7) to hold annual meetings. 
In fulfilling these objectives, many of the past accomplishments 
of the SVS were forged in collaboration with the North American 
Chapter of the International Society for Cardiovascular Surgery via 
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the mechanism of the Joint Council of the two Societies. These 
accomplishments arewell known and need not be recapitulated 
here. It is worth emphasizing, however, that both of these Societies 
working in concert provided the impetus that led to improved 
training in vascular surgery and, ultimately, to its recognition as a 
subspecialty, with Certificates of Special and Added Qualifications 
being awarded by the American Board of Surgery to those who had 
completed an approved residency ear in vascular surgery and 
passed both a written and an oral examination} TM Moreover, both 
of these Societies, again working in concert via the Government 
Relations Committee of the Joint Council, have represented the 
needs of vascular surgeons and their patients in the increasingly 
complex interactions between government and those who practice 
vascular surgery. 
However, some surgeons who devote a major proportion of 
their time to the care of vascular disease patients believe themselves 
to be disenfranchised and poorly represented by the two major 
vascular societies. They believe the leadership of the two Societies 
to be so far removed from "the trenches of vascular surgical 
practice" that hey offer poor representation. They believe that he 
SVS, in particular, represents an elitist organization that is out of 
touch with the collective needs of the practicing vascular surgeon 
and often fails to address these needs. Although some of these 
criticisms may have been justified, the current leadership of the two 
Societies is aware that hey must represent the needs of all surgeons 
who specialize in vascular surgery. The SVS, through the mecha- 
nism of the Joint Council of the two major national Societies, must 
continue to meet the educational, political, and other collective 
needs of vascular disease patients and vascular surgeons, i.e., 
specialists in vascular surgery. 
Discrete role o f  the SVS. If the latter functions are to be 
fulfilled by the Joint Council of the two Societies, what is the 
discrete role for the preeminent and highly esteemed SVS? Its 
primary discrete role is to provide recognition for excellence in 
vascular surgery. This excellence can be in the sphere of basic 
scientific ontributions related to vascular disease management. It 
can be in important clinical innovations related to vascular disease 
treatment. I  can be in administrative or organizational leadership 
or accomplishments in the interest of the specialty. It can be in 
outstanding educational contributions. Finally, it can be in recog- 
nition of excellence in any combination of all five spheres. Mem- 
bership in the SVS has been and should continue to be awarded for 
the achievement of excellence in one or more of these five spheres. 
In addition, for an organization whose primary overall goal is 
to provide ieadership for vascular surgery and whose primary 
discrete role is to facilitate the recognition of excellence in vascular 
surgery, acrucial secondary ole will be the selection of the best and 
brightest in the specialty as officers and leaders who can by their 
participation i Joint Council functions be activists in defining 
issues of importance toall specialists in vascular surgery and their 
patients and in determining strategies todeal with these issues most 
effectively. The Strategic Planning Group, an advisory committee 
of the Joint Council, was initiated to analyze issues that are crucial 
to the future of vascular surgery and to develop long-term action 
plans to deal with these issues in an organized, consistent, and 
proactive fashion. The E. Stanley Crawford Critical Issues Forum of 
the SVS will continue to be a portion of the annual meeting that is 
set aside to honor the memory of Dr. Crawford. This part of the 
program is the responsibility of the incoming Society President. 
This Forum, as it has in the past, can continue to be used for 
discussion of issues that are crucial to the future of vascular surgery 
and enlistment of membership support when needed. 
FUTURE IMPORTANT ISSUES FOR VASCULAR 
SURGERY TO ADDRESS 
Postgraduate  ducation. The SVS, working indepen- 
dently or through the Joint Council, must ake a leadership role in 
providing specialists in vascular surgery with the necessary educa- 
tion and training to allow them to deliver optimal care to their 
patients. This is particularly important in this era of rapid innova- 
tion in the vascular field. Vascular surgeons must have the oppor- 
tunity to incorporate new technologic and scientific advances into 
their practices. The skills and knowledge needed to use these new 
technologies must be disseminated byappropriate Society-spon- 
sored postgraduate programs. The introduction this year of the 
ISCVS/SVS Endovascular Surgery Workshop Course represents 
the beginning of such a postgraduate educational effort. 
Credent ia l ing in new technologies.  Although creden- 
tialing to perform various therapeutic procedures i a process 
carried out at a local, hospital level, the SVS should take a leadership 
role in producing uidelines that will assist specialists in vascular 
surgery in obtaining adequate experience tobe credentialed in new 
procedures when they are proven to be safe and effective. When 
necessary, the Society should define and establish suitable mecha- 
nisms for obtaining the appropriate experience tofacilitate creden- 
tialing. This certainly includes the skill s and experience toperform 
less-invasive endovascular nd endoscopic procedures a their safety 
and effectiveness are documented. 
Relat ionships wi th  other  specialties and the govern- 
ing bodies o f  general surgery. Working together with the 
Association of Program Directors in Vascular Surgery, the SVS must 
take the lead in addressing issues of concern and disagreement 
between vascular surgery and other specialties, including eneral 
surgery. This mandates a continuing dialogue with the American 
Board of Surgery, the Residency Review Committee inSurgery, and 
their parent bodies--the American Board of Medical Specialties 
and the Accreditation Council on Graduate Medical Education. 
Similarly, the SVS should maintain a dialogue with other specialties 
interested in providing care to vascular disease patients. These 
include interventional radiology, interventional cardiology and 
vascular medicine. The goal of the Society in all of these interactions 
and relationships should be to support actions that will be in the 
best interests of vascular disease patients rather than the parochial 
interests of one or another physician group. In this regard, itseems 
logical that he best, most cost-effective care in vascular disease will 
be provided by multispecialty groups working together as a single 
administrative unit. In this way, turf issues and other detrimental 
effects of interspecialty competition could be minimized. 2'3 
Determinat ion  o f  workforce requirements.  With all 
the disparate forces that will impact medicine in the next decade, it
is imperative that he SVS continue to update data on who is doing 
what in vascular disease treatment, so that accurate projections of 
workforce requirements can be made and appropriate actions 
taken. Excessive numbers of well-trained vascular surgeons can be 
almost as detrimental tothe welfare of vascular disease patients as 
inadequate numbers. 
Suppor t  fund ing  mechanisms for  vascular disease 
research. In this arena too, the SVS should continue the effort it 
has already initiated to be sure that adequate monies are provided 
by the federal government and other sources to fund high-quality 
basic and clinical research to improve vascular disease management. 
As in other areas, the basic goal must be the well-being of vascular 
disease patients, even if it means adecreased workload for vascular 
surgeons and decreased workforce requirements in the future. 
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Def in i t ion o f  a "vascular surgeon"  and the relat ion- 
ship w i th  other  vascular societies. The SVS is a small society. 
The International Society for Cardiovascular Surgery is larger but 
does not have as members all who consider themselves vascular 
surgeons. One reason is that a clear definition of a vascular surgeon 
is lacking. Vascular surgery is considered by some to be a compo- 
nent of general surgery and does not have a discrete Board. Yet most 
general surgeons without special training in vascular surgery do few 
vascular cases, and this trend is increasing. 7'12 What then is a 
"vascular surgeon" or a specialist in vascular surgery? There are 
many reasons why this is not an easy definition to provide and why 
opinions regarding such a definition may vary. Certainly all would 
agree that every general surgeon or thoracic surgeon is not a 
vascular surgeon. In addition, even though surgeons with certifi- 
cates of added or special qualifications do abundant vascular 
operations, they also perform substantial numbers of nonvascular 
general surgical operations. Finally, there are disenfranchised vas- 
cular surgeons who have had training and experience virtually 
similar to certified vascular surgeons, and who devote the predomi- 
nant part of their practice to vascular disease patients, but who are 
not permitted tosit for the American Board of Surgery examination 
in vascular surgery. It seems clear that a definition of a "vascular 
surgeon" issorely needed, and I offer one that seems to meet he 
requirement ofidentifying individuals who are reasonably assured 
of providing optimal care to vascular disease patients. A vascular 
surgeon is a specialist in vascular surgery who has completed at least 1 
year of senior level training or its equivalent in vascular surgery and 
vascular disease management, who devotes more than 50% of his or her 
practice to vascular disease patients, and who performs more than 50 
major vascular operations per year. 
What is the relationship between the SVS and the vascular 
surgeons who meet this definition? Even though many well- 
qualified vascular surgeons may not be members of the SVS, it is 
clear that this leading Society in our specialty must speak for, 
represent, and meet he collective needs of all specialists invascular 
surgery and the patients for whom they care. It must meet heir 
educational nd credentialing needs. It must represent them in 
contentious and noncontentious is ues between vascular surgery 
and other medical specialties, the governing bodies in surgery and 
medicine, and our governments. It must provide the voice and the 
leadership for all specialists in vascular surgery during the tumul- 
tuous times ahead. It must be out in the forefront in defining the 
issues that are critical to vascular surgery and in fighting the 
necessary battles over these issues. In all of these aspects of 
leadership, the SVS must be motivated primarily to act in the 
interests of the well-being of vascular disease patients. 
How can a small society with limited membership l ke the SVS 
provide the strong leadership for all specialists in vascular surgery? 
The mechanism is largely in place. Leaders of the SVS function 
within the Joint Council umbrella that represents the majority of 
true vascular surgeons inNorth America. Recently arepresentative 
from the major regional vascular societies has been added to the 
Joint Council, and the President of the Society for Clinical Vascular 
Surgery has been invited to participate inJoint Council activities. A
similar arrangement could be worked out with the Peripheral 
Vascular Society. By functioning as leaders of the Joint Council of 
the two major national vascular societies, which has representation 
from the other U.S. and Canadian vascular societies, the leaders of 
the SVS can fairly represent and speak with a strong voice for all 
North American vascular surgeons and vascular disease patients. If
the SVS meets its obligation to recognize and support excellence in 
vascular surgery, it will select as leaders individuals who have the 
insight and courage to identify important issues and fight important 
battles for all vascular surgeons and their patients. These leaders 
hopefully will have the wisdom to build consensus, the ability to 
identify courses of action that are both attainable and right, and the 
commitment to bring about necessary changes that are in the 
interests of vascular surgery and the patients we all care for with 
serious non-cardiac vascular diseases. 
REFERENCES 
1. Parsons RE, Matin ML, Veith FJ, et al. Fhioroscopically 
assisted thromboembolectomy: an improved method for treat- 
ing acute occlusions of native arteries and bypass grafts. Ann 
Vase Surg 1996;10:201-10. 
2. Veith FJ. Presidential ddress: transluminally placed endovas- 
cular stented grafts and their impact on vascular surgery. J Vase 
Surg 1994;20:855-60. 
3. VeithFJ, MarinML. Endovascular surgery and its effect onthe 
relationship between vascular surgery and radiology. J Endo- 
vase Surg 1995;2:1-7. 
4. Veith FJ, Abbott WM, Yao JST, et al. Guidelines for develop- 
ment and use oftranshiminally placed endovascular prosthetic 
grafts in the arterial system. J Vase Surg 1995;21:670-85 and 
J Vase Interv Radiol 1995 ;6:477-92. 
5. U.S. Bureau of the Census. Current population reports. 
Special studies. P23 - 178. Sixty-five plus in America. Washing- 
ton D.C.: Government Printing Office, 1993. 
6. U.S. Bureau of the Census Statistical Abstract of the United 
States: Current Population Reports (114th ed.). U.S. Depart- 
ment of Commerce, Washington D.C., 1994. 
7. Stanley JC, Barnes RW, Ernst CB, Hertzer NR, Mannick JA, 
Moore WS. Vascular surgery in the United States: workforce 
issues. J Vase Surg 1996;23:172-81. 
8. Veith FJ, Gupta SK, Wengerter KR, et al. Impact of nonop- 
erative therapy on the clinical management of peripheral 
arterial disease. Circulation 1991 ;83(suppl 1):I137-42. 
9. Annual Report and Reference Handbook--1992. Evanston, 
Ill.: American Board of Medical Specialties, Research and 
Education Foundation, i992:95-6. 
10. DeWeese JA. Presidential ddress: the vascular societies--how 
involved should they be? J Vase Surg 1986;3:1-9. 
11. DeWeese IA. Should vascular surgery become an independent 
specialty? J Vase Surg 1990;12:605-6. 
12. Wheeler HB. Should vascular surgery become an independent 
specialty? Implications of data about operative xperience. 
J Vase Surg 1990;12:619-28. 
Submitted Mar. 18, 1996; accepted Mar. 25, 1996. 
